Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 1;461:21-30.
doi: 10.1016/j.canlet.2019.06.011. Epub 2019 Jun 20.

Frequent Amplifications of ESR1, ERBB2 and MDM4 in Primary Invasive Lobular Breast Carcinoma

Affiliations
Free PMC article

Frequent Amplifications of ESR1, ERBB2 and MDM4 in Primary Invasive Lobular Breast Carcinoma

Lan Cao et al. Cancer Lett. .
Free PMC article

Abstract

Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer following invasive ductal carcinoma (IDC). To identify potential genetic drivers of ILC progression, we used NanoString nCounter technology to investigate the DNA copy number (CN) in 70 well-curated primary ILC samples. We confirmed prior observations of frequent amplification of CCND1 (33%), and MYC (17%) in ILC, but additionally identified a substantial subset of ILCs with ESR1 and ERBB2 (19%) amplifications. Of interest, tumors with ESR1 CN gains (14%) and amplification (10%) were more likely to recur compared to those with normal CN. Finally, we observed that MDM4 (MDMX) was amplified in 17% of ILC samples. MDM4 knockdown in TP53 wild-type ILC cell lines caused increased apoptosis, decreased proliferation associated with cell cycle arrest, and concomitant activation of TP53 target genes. Similar effects were seen in TP53 mutant cells, indicting a TP53-independent role for MDM4 in ILC. To conclude, amplification of ESR1 and MDM4 are potential genetic drivers of ILC. These amplifications may represent actionable, targetable tumor dependencies, and thus have potential clinical implications and warrant further study.

Keywords: Amplification; ERBB2; ESR1; ILC; MDM4.

Conflict of interest statement

Conflict of interest: The authors declare they have no conflicts of interest with the contents of this article.

Similar articles

See all similar articles

Cited by 2 articles

MeSH terms

Feedback